𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia

✍ Scribed by Meltzer, H.Y.; Lindenmayer, J.-P.; Kwentus, J.; Share, D.B.; Johnson, R.; Jayathilake, K.


Book ID
123560578
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
374 KB
Volume
154
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Safety and efficacy of long-acting injec
✍ Swapna Verma; Mythily Subramaniam; Edimansyah Abdin; Kang Sim; Alex Su; Nelson L πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

## Abstract The study aimed to evaluate the efficacy of long‐acting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twenty‐five patients enrolled in this 6‐month open labelled study. They were switched from their current antipsychotic to LAR without a prior or